HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” very soon. Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
DividendPress.com is following several dividend stocks including MPW, BANF, AVGO and more.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
AmerisourceBergen
Symbol: ABC
Recent ABC Price: $148.22
Average Analyst Price Target: $173.70 (17.19%)
ABC Market Cap: $30.49B
Expected Ex-Dividend Date for ABC stock: Aug 12 2022
Expected Payment Date for ABC stock: Aug 29 2022
Expected Dividend & Yield for ABC stock: 1.26%
Recent Analyst Action: Lisa Gill, analyst at J.P. Morgan, reiterates coverage on AmerisourceBergen (ABC) stock in the Healthcare sector with a Buy rating and a price target of $ 191 (1 week ago).
Click for full story on ABC stock >>--------------------------------------------------------------------------
Bio-Techne
Symbol: TECH
Recent TECH Price: $374.43
Average Analyst Price Target: $494.43 (32.05%)
TECH Market Cap: $14.91B
Expected Ex-Dividend Date for TECH stock: Aug 12 2022
Expected Payment Date for TECH stock: Aug 29 2022
Expected Dividend & Yield for TECH stock: 0.35%
Recent Analyst Action: Jacob Johnson, analyst at Stephens, reiterates coverage on Bio-Techne (TECH) stock in the Healthcare sector with a Buy rating and a price target of $ 480 (1 week ago).
Click for full story on TECH stock >>--------------------------------------------------------------------------
Chemed
Symbol: CHE
Recent CHE Price: $483.85
Average Analyst Price Target: n/a (11.81%)
CHE Market Cap: $7.25B
Expected Ex-Dividend Date for CHE stock: Aug 12 2022
Expected Payment Date for CHE stock: Sep 02 2022
Expected Dividend & Yield for CHE stock: 0.30%
Recent Analyst Action: Ben Hendrix, analyst at RBC Capital, reiterates coverage on Chemed (CHE) stock in the Healthcare sector with a Buy rating and a price target of $ 541 (1 week ago).
Click for full story on CHE stock >>--------------------------------------------------------------------------
Eli Lilly & Co
Symbol: LLY
Recent LLY Price: $301.17
Average Analyst Price Target: $354.90 (17.84%)
LLY Market Cap: $289.43B
Expected Ex-Dividend Date for LLY stock: Aug 12 2022
Expected Payment Date for LLY stock: Sep 09 2022
Expected Dividend & Yield for LLY stock: 1.21%
Recent Analyst Action: Robyn Karnauskas, analyst at Truist Financial, reiterates coverage on Eli Lilly & Co (LLY) stock in the Healthcare sector with a Buy rating and a price target of $ 348 (4 days ago).
Click for full story on LLY stock >>--------------------------------------------------------------------------
Novo Nordisk
Symbol: NVO
Recent NVO Price: $108.79
Average Analyst Price Target: $133.00 (22.25%)
NVO Market Cap: $243.36B
Expected Ex-Dividend Date for NVO stock: Aug 12 2022
Expected Payment Date for NVO stock: Aug 23 2022
Expected Dividend & Yield for NVO stock: 1.08%
Recent Analyst Action: Michael Leuchten, analyst at UBS, reiterates coverage on Novo Nordisk (NVO) stock in the Healthcare sector with a Sell rating and a price target of n/a (1 month ago).
Click for full story on NVO stock >>--------------------------------------------------------------------------
Organon
Symbol: OGN
Recent OGN Price: $31.69
Average Analyst Price Target: $37.33 (17.80%)
OGN Market Cap: $7.99B
Expected Ex-Dividend Date for OGN stock: Aug 12 2022
Expected Payment Date for OGN stock: Sep 15 2022
Expected Dividend & Yield for OGN stock: 3.57%
Recent Analyst Action: Jason Gerberry, analyst at Bank of America Securities, reiterates coverage on Organon (OGN) stock in the Healthcare sector with a Hold rating and a price target of $ 37 (1 week ago).
Click for full story on OGN stock >>--------------------------------------------------------------------------
Teleflex
Symbol: TFX
Recent TFX Price: $253.87
Average Analyst Price Target: $293.00 (15.41%)
TFX Market Cap: $11.92B
Expected Ex-Dividend Date for TFX stock: Aug 12 2022
Expected Payment Date for TFX stock: Sep 15 2022
Expected Dividend & Yield for TFX stock: 0.55%
Recent Analyst Action: Jayson Bedford, analyst at Raymond James, reiterates coverage on Teleflex (TFX) stock in the Healthcare sector with a Buy rating and a price target of $ 266 (1 week ago).
Click for full story on TFX stock >>--------------------------------------------------------------------------
DividendPress.com helps you find the best performing dividend stocks. We alert our subscribers of coming ex-dividend dates.